Skip to content

AirSculpt Technologies, Inc. AIRS Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

AbbVie logo
AbbVieABBV

Other financials

Income statement

See full
Revenue$39.4M0.0%
Gross profit$23.8M+1.6%
Operating income-$1.8M-13.4%
Net income-$2.4M+15.8%
EPS (diluted)-$0.03+40.0%

Balance sheet

See full
Cash & equivalents$16.7M+201%
Total debt$71.0M-27.1%
Total equity$100.3M+31.5%
Total assets$192.0M-5.5%

Cash flow

See full
Operating cash flow$5.3M+507%
CapEx$51.0K-97.3%
Free cash flow$5.2M+605%

Valuation

See full
Market cap$311.81M+4.7%
Enterprise value$366.14M-6.0%
P/S2.1×+0.3×

Profitability

See full
Gross margin59.6%-0.3pp
Operating margin-7.8%-0.4pp
Net margin-11.3%-25.1pp
FCF margin-0.1%

Returns & leverage

See full
Return on equity-21.6%-78.3pp
Debt / equity0.7×-0.6×
Current ratio0.7×+0.2×

Where this comes from

Reported directly by AirSculpt Technologies, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: AirSculpt Technologies, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about AirSculpt Technologies, Inc.'s common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AirSculpt Technologies, Inc.'s common stock, shares authorized (in shares)?
AirSculpt Technologies, Inc. (AIRS) reported common stock, shares authorized (in shares) of $450M in Q1 2026.
How has AirSculpt Technologies, Inc.'s common stock, shares authorized (in shares) changed year-over-year?
AirSculpt Technologies, Inc.'s common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $450M to $450M.
What is the long-term trend for AirSculpt Technologies, Inc.'s common stock, shares authorized (in shares)?
Over 4 years (2021 to 2025), AirSculpt Technologies, Inc.'s common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $450M to $450M.